ImmunoKey at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

ImmunoKey at BIO-Europe 2026 in Cologne: 1 session (1 talk).

OrganizationBIO-Europe 2026 Attendance
Biotech
UK company developing CAR T-cell therapies for solid cancers, starting with ovarian cancer.
Talk
Wed Nov 11
11:10–11:20
Cell and Gene Therapies: Immunokey
A CAR-T cell therapy for ovarian cancer whose two-receptor design aims to hit more tumor cells while sparing healthy tissue.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from ImmunoKey

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction